Document Detail


Is there a link between inflammation and abnormal lipoprotein profile in Sjögren's syndrome?
MedLine Citation:
PMID:  20378384     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES: To investigate the lipoprotein profile of patients with primary Sjögren's syndrome (pSS) and its association with laboratory tests, including markers of inflammation. METHODS: This is a cross-sectional study among patients with pSS and healthy controls. We analyzed the lipoprotein profile of 73 pSS patients compared to 65 healthy individuals in the control group. We further evaluated possible associations between dyslipidemia in pSS patients and laboratory parameters including: hypergammaglobulinemia, autoantibodies [antinuclear antibodies (ANA), rheumatoid factor (RF), anti-Ro, anti-La], and acute-phase reactants [C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR)]. RESULTS: Patients and controls were comparable regarding the demographic variables. Lipoprotein profile was similar between pSS patients and controls: total cholesterol (204.0+/-43.39 versus 206.5+/-42.76 mg/mL, P=0.73), LDL fraction (131.6+/-37.38 versus 130.62+/-38.24 mg/dL, P=0.88) and HDL fraction (49.7+/-13.5 versus 51+/-11.5mg/dL, P=0.56), triglycerides (129.3+/-81.0 versus 116.8+/-53.5mg/dL, P=0.29). However, patients with pSS had a strong trend to present dyslipidemia when compared to healthy individuals (76.7% versus 61.5%, P=0.06). The presence of dyslipidemia in pSS was associated with increased ESR (44.05+/-28.07 versus 28.28+/-18.00, P=0.03), but not with other laboratory markers of the disease and inflammation. DISCUSSION/CONCLUSION: pSS patients frequently present abnormal lipid profile, which are associated with higher levels of ESR. Thus, similar to other systemic inflammatory diseases such as rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE), lipid profile should be evaluated in pSS patients, with the aim of initiating specific therapeutic strategy for prevention of cardiovascular events.
Authors:
Willian Cruz; Sonia Fialho; Edelton Morato; Gláucio Castro; Adriana Zimmermann; Giovana Ribeiro; Fabrício Neves; Ivânio Pereira
Related Documents :
22083944 - Differential effect of β-blockers for heart rate control in coronary artery disease.
7664504 - Update on the treatment of hypercholesterolemia, with a focus on hmg-coa reductase inhi...
21784604 - The application of infrared thermography in evaluation of patients at high risk for low...
21932594 - Clinical characteristics of adrenocortical tumors in children.
16959304 - Nadroparine activated fibrinolysis and improvement of glomerular filtration rate in pat...
20569994 - Persecutory delusions and the perception of trustworthiness in unfamiliar faces in schi...
Publication Detail:
Type:  Journal Article     Date:  2010-04-07
Journal Detail:
Title:  Joint, bone, spine : revue du rhumatisme     Volume:  77     ISSN:  1778-7254     ISO Abbreviation:  Joint Bone Spine     Publication Date:  2010 May 
Date Detail:
Created Date:  2010-05-25     Completed Date:  2010-08-23     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100938016     Medline TA:  Joint Bone Spine     Country:  France    
Other Details:
Languages:  eng     Pagination:  229-31     Citation Subset:  IM    
Copyright Information:
Copyright 2010 Société française de rhumatologie. Published by Elsevier SAS. All rights reserved.
Affiliation:
Rheumatology Division, Federal University, Santa Catarina, Florianópolis-SC, Brazil.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Antibodies, Antinuclear / blood
Biological Markers / blood*
Blood Sedimentation
C-Reactive Protein / metabolism
Cross-Sectional Studies
Dyslipidemias / blood,  immunology*
Female
Humans
Hypergammaglobulinemia / blood,  immunology
Inflammation / blood,  immunology*
Lipoproteins / blood*
Male
Middle Aged
Rheumatoid Factor / blood
Sjogren's Syndrome / blood,  immunology*
Chemical
Reg. No./Substance:
0/Antibodies, Antinuclear; 0/Biological Markers; 0/Lipoproteins; 0/SS-A antibodies; 0/SS-B antibodies; 9007-41-4/C-Reactive Protein; 9009-79-4/Rheumatoid Factor

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Epidemiology of osteoporosis-related fractures in France: A literature review.
Next Document:  Visceral leishmaniasis and macrophagic activation syndrome in a patient with rheumatoid arthritis un...